Cormorant Asset Management LP 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:02 pm Sale |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Cormorant Asset Management LP | 0 0.000% |
-1,952,032 (Position Closed) |
Filing |
| 2023-02-14 3:15 pm Sale |
2022-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Cormorant Asset Management LP | 1,952,032 8.380% |
-31,136 (-1.57%) |
Filing |
| 2021-07-09 4:06 pm Purchase |
2021-06-29 | 13G | Elevation Oncology, Inc. ELEV |
Cormorant Asset Management LP | 1,983,168 8.690% |
1,983,168 (New Position) |
Filing |